Crescent Biopharma, Inc. (CBIO)
18.51
+0.58
(+3.23%)
USD |
NASDAQ |
Sep 02, 16:00
18.51
0.00 (0.00%)
After-Hours: 20:00
Crescent Biopharma Price to Book Value : 3.226 for Sept. 2, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 01, 2026 | 3.125 |
| August 31, 2026 | 2.893 |
| August 28, 2026 | 3.094 |
| August 27, 2026 | 3.095 |
| August 26, 2026 | 3.141 |
| August 25, 2026 | 2.963 |
| August 24, 2026 | 2.958 |
| August 21, 2026 | 2.989 |
| August 20, 2026 | 2.829 |
| August 19, 2026 | 3.019 |
| August 18, 2026 | 2.909 |
| August 17, 2026 | 3.046 |
| August 14, 2026 | 2.987 |
| August 13, 2026 | 2.898 |
| August 12, 2026 | 2.864 |
| August 11, 2026 | 2.909 |
| August 10, 2026 | 3.020 |
| August 07, 2026 | 2.935 |
| August 06, 2026 | 2.864 |
| August 05, 2026 | 2.748 |
| August 04, 2026 | 2.855 |
| August 03, 2026 | 2.592 |
| July 31, 2026 | 2.522 |
| July 30, 2026 | 2.618 |
| July 29, 2026 | 2.574 |
| Date | Value |
|---|---|
| July 28, 2026 | 2.865 |
| July 27, 2026 | 2.951 |
| July 24, 2026 | 2.841 |
| July 23, 2026 | 2.968 |
| July 22, 2026 | 2.759 |
| July 21, 2026 | 2.900 |
| July 20, 2026 | 2.623 |
| July 17, 2026 | 2.571 |
| July 16, 2026 | 2.634 |
| July 15, 2026 | 2.731 |
| July 14, 2026 | 2.668 |
| July 13, 2026 | 2.735 |
| July 10, 2026 | 3.022 |
| July 09, 2026 | 2.921 |
| July 08, 2026 | 2.930 |
| July 07, 2026 | 2.968 |
| July 06, 2026 | 2.956 |
| July 02, 2026 | 2.979 |
| July 01, 2026 | 2.977 |
| June 30, 2026 | 3.137 |
| June 29, 2026 | 2.760 |
| June 26, 2026 | 2.845 |
| June 25, 2026 | 2.605 |
| June 24, 2026 | 2.661 |
| June 23, 2026 | 2.683 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Encompass Health Corp. | 4.607 |
| Myriad Genetics, Inc. | 1.018 |
| BioRestorative Therapies, Inc. | 1.705 |
| U.S. Stem Cell, Inc. | -- |
| Marijuana, Inc. | 0.0293 |
Price to Book Value Related Metrics
| PS Ratio | 38.02 |
| Price | 18.51 |
| Earnings Yield | -41.32% |
| Market Cap | 513.76M |